AdvertisementKotton said the Johnson & Johnson “one-and-done” jab is especially well-suited to the needs of her patients, including organ transplant recipients leaving the hospital on immune-suppressing drugs and homebound people with compromised immunity. Many of Kotton’s patients had been scheduled to get the Johnson & Johnson shot over the next few days. The cases emerged from reports made either to Johnson & Johnson or to the Vaccine Adverse Event Reporting System, a database run by the CDC and the Food and Drug Administration. In addition, many men with unusual blood clots have shown up in Europe and the United Kingdom after a shot of AstraZeneca’s COVID-19 vaccine, which is similar to the one from Johnson & Johnson. Dr. Anthony Fauci, the nation’s leading expert on infectious diseases, said he hopes the Johnson & Johnson pause will be seen as a sign that officials are taking safety issues seriously and haven’t “cut corners” in the vaccine-development process.

Source: Los Angeles Times April 16, 2021 23:15 UTC